Neurology & Neurosurgery Research
POST COVID-19 POTS Study
Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult patients with Post–COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
AGE: 18+ years old
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: Yes
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: Yes
TYPE: Investigational Treatment Study
CONDITION: Postural Orthostatic Tachycardia Syndrome, POTS
CONDITION: Postural Orthostatic Tachycardia Syndrome, POTS
LOCATION: University Hospitals Cleveland Medical Center, UH Minoff Health Center
This study is currently closed to enrollment.
Study Purpose
This study is examining the safety of an investigational drug in people with POST COVID-19 postural orthostatic tachycardia syndrome (POTS) and how well people tolerate it. It is also looking at how well the study drug works and is processed in people who have post-COVID-19 POST COVID-19 POTS.
Who Can Participate
Participants 18 years of age and older who have diagnosed with new-onset POTS post-COVID-19 may be eligible for this study.